Roche launches 3 monkeypox virus rapid screening reagents, and more than 10 domestic pharmaceutical companies are deployed

The monkeypox virus is still spreading and has now spread to more than 20 countri.

On May 25, local time, Roche and its subsidiary TIB Molbiol jointly announced that they have developed three rapid screening reagents for the detection of monkeypox vir.

• The first kit to detect orthopoxviruses, including all forms of monkeypox viruses originating in West and Central Africa;

• The second kit is a specific test for monkeypox virus only, specifically for West and Central African strains;

• The third kit detects both orthopoxvirus and monkeypox vir.

Previously, on December 1, 2021, Roche announced the completion of the acquisition of its partner TIB Molbiol to respond to the new crown epidemic and increase the field of infectious disease detecti.

The two companies will focus on rapidly developing polymerase chain reaction (PCR) assays and diagnostic tests to address emerging pathogens and potential health threats to COVID-1 It is reported that for more than 20 years, the two companies have been cooperating on the research of infectious diseases and epidemic viruses, including: SARS, anthrax, avian influenza virus H5N1, MERS, new influenza virus H1N1, Ebola virus, Zika virus, SARS-CoV -2 virus and its variant strains,e.

Within days of completing the acquisition, Roche announced the development of three research kits for the new coronavirus variant, Omicron, that can quickly and accurately identify Omicr.

"Diagnostic tools are critical to addressing and ultimately controlling emerging public health challenges as they advance responses such as tracing efforts and treatment strategies," Roche Diagnostics CEO Thomas Schnecker said in a stateme.

Roche said the test kits are now available for research in most countries around the wor.

In addition, BARDA said last week that it would spend $119 million in a deal with Bavarian Nordic to exercise options on Jynneos' freeze-dried stocks, which include monkeypox and smallp.

At the same time, more than 10 domestic biopharmaceutical companies, including Shuoshi Bio, Shengxiang Bio, Zhijiang Bio, Rejing Bio, and Huada Gene, also issued announcements one after another, saying that they have monkeypox virus monitoring reagent products or have developed monkeyp.